Covid-19 is a serious virus related to severe illness courses. The main complication of this virus is venous thromboembolism which includes pulmonary embolism and deep vein thrombosis. Doppler ultrasound is becoming increasingly accepted as an accurate, non-invasive modality of imaging in suspected DVT. To evaluate the prevalence of DVT using Doppler sonography among COVID-19 patients concerning clinical and laboratory findings at Taif City, Saudi Arabia, and to determine the D-dimer elevation in DVTs patients and its association with the high-altitude regions. This is a retrospective study conducted at King Faisal Hospital, Taif. Including 150 Patients. Lower limb Doppler ultrasound was performed on all patients admitted either to the ward or intensive care unit between April to December 2021. Clinical and laboratory features, thrombotic complications, and outcomes were assessed.150 patients were screened in this study including 96 female and 54 male. DVT was found in 86 patients (57.3%) while those who didn't complain of DVT represented (42.7%). The mean age was (>64) years, and most of the respondents were inpatients (70.0%), while Isolation, ICU, and ER accounted represented (12.7%, 11.3%, and 6.0%) respectively. Also, (54.7%) of patients who complained of DVT had an increase in D-dimer values, compared to inpatients that didn't complain of DVT. Ultrasound is a helpful tool for detecting DVT in COVID-19 patients., based on the large percentage of people with venous thrombosis. Also, this study proved that there is a statistically significant association between DVT and elevated D-dimer among confirmed COVID-19 patients who live in Taif City.
1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.
2. WHO director-general's remarks at the media briefing on 2019-nCoV on 11 February 2020. 2020.
3. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-9.
4. Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 2020;57(6):365-88.
5. Nopp S, Moik F, Jilma B, Pabinger I, Ay C. Risk of venous thromboembolism in patients with COVID‐19: a systematic review and meta‐analysis. Res Pract Thromb Haemost. 2020;4(7):e12439.
6. Kunutsor SK, Laukkanen JA. Incidence of venous and arterial thromboembolic complications in COVID-19: a systematic review and meta-analysis. Thromb Res. 2020;196:27-30.
7. Jenab Y, Ghafouri P, Hosseini K, Shirani S, Shirzad M. Bilateral proximal deep vein thrombosis and COVID‐19 in a patient with absence of inferior vena cava: A case report and review of literature. Clin Case Rep. 2022;10(6):e5972.
8. Franco‐Moreno A, Herrera‐Morueco M, Mestre‐Gómez B, Muñoz‐Rivas N, Abad‐Motos A, Salazar‐Chiriboga D, et al. Incidence of deep venous thrombosis in patients with COVID‐19 and pulmonary embolism: compression ultrasound COVID study. J Ultrasound Med. 2021;40(7):1411-6.
9. Lu YF, Pan LY, Zhang WW, Cheng F, Hu SS, Zhang X, et al. A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19. Int J Infect Dis. 2020;100:34-41.
10. Wang T, Chen R, Liu C, Liang W, Guan W, Tang R, et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020;7(5):e362-3.
11. ALGhasab NS, Altamimi LA, Alharbi MS, ALMesned SS, Khetan AK. Venous thromboembolism in COVID-19. Saudi Med J. 2022;43(9):979-90.
12. Kainz B, Heinrich MP, Makropoulos A, Oppenheimer J, Mandegaran R, Sankar S, et al. Non-invasive diagnosis of deep vein thrombosis from ultrasound imaging with machine learning. NPJ Digit Med. 2021;4(1):137.
13. Baker M, Anjum F, dela Cruz J. Deep Venous Thrombosis Ultrasound Evaluation. InStatPearls [Internet] 2022 Aug 8. StatPearls Publishing.
14. Naringrekar H, Sun J, Ko C, Rodgers SK. It's not all deep vein thrombosis: Sonography of the painful lower extremity with multimodality correlation. J Ultrasound Med. 2019;38(4):1075-89.
15. Demelo-Rodríguez P, Cervilla-Muñoz E, Ordieres-Ortega L, Parra-Virto A, Toledano-Macías M, Toledo-Samaniego N, et al. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thromb Res. 2020;192:23-6.
16. Bhadarge G, Bankar N, Hadke S. Study of liver function test, haematological parameters and Crp derangements in covid-19 patients. Bioscience Biotechnol Res Commun. 2021;14(6):36-40.
17. Stubbs MJ, Mouyis M, Thomas M. Deep vein thrombosis. BMJ. 2018;360:k351.
18. Baroiu L, Lese AC, Stefanopol IA, Iancu A, Dumitru C, Ciubara AB, et al. The Role of D-Dimers in the Initial Evaluation of COVID-19. Ther Clin Risk Manag. 2022;2022(18):593-4.
19. Basims R. Plasma d-dimer level correlated with advanced breast carcinoma in female patients. Ann Med Surg (Lond). 2018;36:75-8.
20. Srivastava S. Travelling to High Altitudes Could be Thrombogenetic, Arch Pulmonol Respir Care. 2015;1(1):23-270.
21. He X, Yao F, Chen J, Wang Y, Fang X, Lin X, et al. The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients. Sci Rep. 2021;11(1):1830.
Copyright © 2024 Archives of Pharmacy Practice. Authors retain copyright of their article if they are accepted for publication.
Developed by Archives of Pharmacy Practice